TGFB1 and chronic obstructive pulmonary disease: miR-145 is highly expressed in SMCs and has a well-documented role in airway pathophysiology, including the release of pro-inflammatory cytokines from SMCs in COPD patients, where its expression is controlled by TGF-β1 [35,36].